Broadpoint Downgrades Express Scripts (ESRX) to Buy
More News related to ESRX
- Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines
- Express Scripts Reports New Threats Tied to Data Security Breach
- Express Scripts (ESRX) Warns of Potential Large Data Breach Tied to Threat
- Express Scripts Warns of Potential Large Data Breach Tied to Threat
- Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: WMT, EYE, ESRX, EXP, QLGC, NSM
More News related to Downgrades
- B. Riley Downgrades Hot Topic (HOTT) to Neutral
- Sidoti Downgrades Movado (MOV) to Neutral
- Sidoti Downgrades Churchill Downs (CHDN) to Neutral
- Sidoti Downgrades The Pantry (PTRY) to Neutral
- Sterne Agee Downgrades ATP Oil & Gas (ATPG) to Hold
Broadpoint Capital downgrades Express Scripts (Nasdaq: ESRX) from Strong Buy to Buy.
Express Scripts, Inc. provides a range of pharmacy benefit management services in North America.
Related Categories
DowngradesStocks Mentioned
+1.02Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
